Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?

Published:2011-01 Issue:4 Volume:22 Page:402-404
ISSN:1043-321X
Container-title:Breast Diseases: A Year Book Quarterly
language:en
Short-container-title:Breast Diseases: A Year Book Quarterly

Author:

De Los Santos J.F.

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference11 articles.

1. Future of personalized medicine in oncology: a systems biology approach;Gonzalez-Angulo;J Clin Oncol,2010

2. Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial;Broët;Breast Cancer Res Treat,1999

3. Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy;Gazet;Ann Oncol,2001

4. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis;Mauri;J Natl Cancer Inst,2005

5. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS);Mauriac;Ann Oncol,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3